XML 59 R46.htm IDEA: XBRL DOCUMENT
v3.25.1

Financial Instruments - Narrative (Details) $ / shares in Units, $ in Thousands | Jun. 26, 2024 USD ($) shares | Mar. 31, 2025 USD ($) $ / shares shares | Feb. 18, 2025 USD ($) $ / shares shares | Dec. 31, 2024 USD ($) shares | Aug. 15, 2024 operatingEntity warrant shares | May 24, 2024 shares | Apr. 30, 2024 USD ($) $ / shares shares | Mar. 31, 2024 USD ($) | Dec. 31, 2023 USD ($) shares | Oct. 02, 2023 USD ($) | Aug. 10, 2023 USD ($) $ / shares shares
--- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | ---
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  | 7,402,541 |  | 7,311,278 |  |  |  |  |  |  | 14,266,605
Exercise price of warrants (in dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 11.50
Contingent earnout liability | $ |  | $ 8,221 |  | $ 7,401 |  |  |  |  |  |  | $ 28,900
Warrant and SEPA liabilities | $ |  | 9,459 |  | 8,316 |  |  |  |  |  |  | $ 28,900
Revenue base redemption feature, amount | $ |  |  |  |  |  |  | $ 729 |  |  |  |
Issuance costs | $ | $ 1,700 |  |  |  |  |  |  |  |  |  |
SEPA derivative liability |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
SEPA derivative liability | $ |  | $ 23 |  | $ 55 |  |  |  | $ 366 | $ 185 | $ 200 |
Public Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  | 1,751,825 |  | 1,751,825 |  |  |  |  |  |  | 8,333,272
Exercise price of warrants (in dollars per share) | $ / shares |  |  |  |  |  |  |  |  |  |  | $ 11.50
Warrant and SEPA liabilities | $ |  | $ 2,100 |  | $ 1,900 |  |  |  |  |  |  | $ 1,500
Class of warrant or right, number of securities called by each warrant or right (in shares) |  |  |  |  |  | 0.27 |  |  |  |  | 1
Number of warrants exchanged (in shares) |  |  |  |  |  | 6,529,954 |  |  |  |  |
Private Placement And Working Capital Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  |  |  |  |  |  |  |  |  |  | 5,933,333
Private Placement Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  | 4,428,648 |  | 4,428,648 |  |  |  |  | 4,933,333 |  | 4,933,333
Warrant and SEPA liabilities | $ |  | $ 5,400 |  | $ 4,900 |  |  |  |  |  |  | $ 900
Number of warrants exchanged (in shares) |  |  |  |  |  | 504,685 |  |  |  |  |
Working capital warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  | 1,000,000 |  | 1,000,000 |  |  |  |  | 1,000,000 |  | 1,000,000
Warrant and SEPA liabilities | $ |  | $ 1,200 |  | $ 1,100 |  |  |  |  |  |  | $ 200
Number of warrants exchanged (in shares) | 0 |  |  |  |  |  |  |  |  |  |
SPAC Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrant and SEPA liabilities | $ |  | $ 8,700 |  | $ 7,900 |  |  |  |  |  |  |
Initial OrbiMed Warrant |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants (in dollars per share) | $ / shares |  | $ 9.3722 |  |  |  |  | $ 9.5562 |  |  |  |
Warrants to purchase common stock (in shares) |  |  |  |  |  |  | 130,805 |  |  |  |
Outstanding warrant liabilities | $ |  | $ 1,230 |  |  |  |  | $ 1,250 |  |  |  |
Number of warrants after split | warrant |  |  |  |  | 2 |  |  |  |  |  |
Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants | operatingEntity |  |  |  |  | 2,000 |  |  |  |  |  |
Initial OrbiMed Warrant, Substitute Warrant Certificate Number One |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase common stock (in shares) |  |  |  |  | 92,801 |  |  |  |  |  |
Initial OrbiMed Warrant, Substitute Warrant Certificate Number Two |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase common stock (in shares) |  |  |  |  | 38,004 |  |  |  |  |  |
Subsequent OrbiMed Warrants, Entity One |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase common stock (in shares) |  |  | 64,748 |  |  |  |  |  |  |  |
Subsequent OrbiMed Warrants, Entity Two |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants to purchase common stock (in shares) |  |  | 26,515 |  |  |  |  |  |  |  |
Subsequent OrbiMed Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Exercise price of warrants (in dollars per share) | $ / shares |  |  | $ 5.4787 |  |  |  |  |  |  |  |
Outstanding warrant liabilities | $ |  |  | $ 500 |  |  |  |  |  |  |  |
OrbiMed Warrants liability |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Warrants outstanding (in shares) |  | 222,068 |  | 130,805 |  |  |  |  |  |  |
Revenue base redemption feature, amount | $ |  | $ 700 |  | $ 400 |  |  |  |  |  |  |
Public Warrants, Private Placement Warrants And Working Capital Warrants |  |  |  |  |  |  |  |  |  |  |
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] |  |  |  |  |  |  |  |  |  |  |
Outstanding warrant liabilities | $ | $ 11,900 |  |  |  |  |  |  |  |  |  |
Class of warrant or right, number of securities called by each warrant or right (in shares) |  |  |  |  |  | 0.30 |  |  |  |  |
Warrants and rights outstanding, net of issuance costs | $ | $ 10,200 |  |  |  |  |  |  |  |  |  |

X
- Definition Class Of Warrant Or Right, Number Of Operating Entities Holding Warrants + References No definition available. + Details
Name: | tlsi_ClassOfWarrantOrRightNumberOfOperatingEntitiesHoldingWarrants
Namespace Prefix: | tlsi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Class Of Warrant Or Right, Warrant Split, Number Of New Warrants + References No definition available. + Details
Name: | tlsi_ClassOfWarrantOrRightWarrantSplitNumberOfNewWarrants
Namespace Prefix: | tlsi_
Data Type: | xbrli:integerItemType
Balance Type: | na
Period Type: | instant

X
- Definition Class Of Warrant Or Right, Warrants Exchanged + References No definition available. + Details
Name: | tlsi_ClassOfWarrantOrRightWarrantsExchanged
Namespace Prefix: | tlsi_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Revenue Base Redemption Feature, Amount + References No definition available. + Details
Name: | tlsi_RevenueBaseRedemptionFeatureAmount
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Warrants and Rights Outstanding, Net Of Issuance Costs + References No definition available. + Details
Name: | tlsi_WarrantsAndRightsOutstandingNetOfIssuanceCosts
Namespace Prefix: | tlsi_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Amount of decrease in additional paid in capital (APIC) resulting from direct costs associated with issuing stock. Includes, but is not limited to, legal and accounting fees and direct costs associated with stock issues under a shelf registration. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1 + Details
Name: | us-gaap_AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Amount of liability recognized arising from contingent consideration in a business combination, expected to be settled beyond one year or the normal operating cycle, if longer. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 805 -SubTopic 30 -Name Accounting Standards Codification -Section 35 -Paragraph 1 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479613/805-30-35-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479668/805-30-25-6 + Details
Name: | us-gaap_BusinessCombinationContingentConsiderationLiabilityNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Exercise price per share or per unit of warrants or rights outstanding. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 210 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147483466/210-20-50-3 + Details
Name: | us-gaap_DerivativeLiabilitiesNoncurrent
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 100 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-100 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-3 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2)(i) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_WarrantsAndRightsOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Details
Name: | us-gaap_FairValueByLiabilityClassAxis=tlsi_StandbyEquityPurchaseAgreementSEPADerivativeLiabilityMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_PublicWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_PrivatePlacementAndWorkingCapitalWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_PrivateWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_WorkingCapitalWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_SPACWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_InitialOrbiMedWarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_InitialOrbiMedWarrantSubstituteWarrantCertificateNumberOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_InitialOrbiMedWarrantSubstituteWarrantCertificateNumberTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_SubsequentOrbiMedWarrantsEntityOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_SubsequentOrbiMedWarrantsEntityTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_SubsequentOrbiMedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_OrbiMedWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=tlsi_PublicWarrantsPrivatePlacementWarrantsAndWorkingCapitalWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |